Covance Softsol Intrinsic Value
Covance Softsol (COVANCE) median intrinsic value is ₹130.91 from 8 valuation models (range ₹67–₹142), vs current price ₹212.95 — -38.5% downside (Trading Above Calculated Value), margin of safety -62.7%. Analyse COVANCE FII DII holdings to track promoter, FII and institutional holdings.
COVANCE Valuation Methods Summary — DCF, Graham Number & P/E
Covance Softsol intrinsic value across 8 models vs current price ₹212.95 — upside/downside and value range per method. For current market price and key ratios, visit Covance Softsol screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹136.80 | ₹109.44 - ₹164.16 | -35.8% | EPS: ₹11.40, Sector P/E: 12x |
| Book Value Method | asset | ₹76.82 | ₹69.14 - ₹84.50 | -63.9% | Book Value/Share: ₹76.82, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹66.91 | ₹60.22 - ₹73.60 | -68.6% | Revenue/Share: ₹83.64, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹141.82 | ₹127.64 - ₹156.00 | -33.4% | EBITDA: ₹52.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹72.96 | ₹65.66 - ₹80.26 | -65.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹93.94 | ₹84.55 - ₹103.33 | -55.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹130.91 | ₹117.82 - ₹144.00 | -38.5% | ROE: 14.2%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹140.37 | ₹126.33 - ₹154.41 | -34.1% | EPS: ₹11.40, BVPS: ₹76.82 |
COVANCE Intrinsic Value vs Market Price — All Valuation Models
Covance Softsol fair value range ₹67–₹142 vs current market price ₹212.95 across 8 valuation models. Read Covance Softsol dividend payments for the complete payout history and dividend yield track record.
COVANCE Intrinsic Value Analysis — Undervalued or Overvalued?
Covance Softsol median intrinsic value ₹130.91, current price ₹212.95 — Trading Above Calculated Value by 38.5%, margin of safety -62.7%.
What is the intrinsic value of COVANCE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Covance Softsol (COVANCE) is ₹130.91 (median value). With the current market price of ₹212.95, this represents a -38.5% variance from our estimated fair value.
The valuation range spans from ₹66.91 to ₹141.82, indicating ₹66.91 - ₹141.82.
Is COVANCE undervalued or overvalued?
Based on our multi-method analysis, Covance Softsol (COVANCE) appears to be trading above calculated value by approximately 38.5%.
COVANCE Financial Health — Key Ratios vs Industry Benchmarks
Covance Softsol financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.81 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.2% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 23.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
COVANCE Cash Flow Quality — Operating & Free Cash Flow
Covance Softsol operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹18 Cr | ₹14 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |